SCP Scope Fluidics S.A.
Scope Fluidics S.A., a biotechnology company, designs and develops projects based on microfluidic technologies in medical diagnostics and healthcare in Poland. It offers BacterOMIC, an antibiotic susceptibility testing. Scope Fluidics S.A. was founded in 2010 and is headquartered in Warsaw, Poland.…
Industry Peers
Diagnostics & ResearchKey Statistics
About Scope Fluidics (WSE: SCP)
›
Scope Fluidics (WSE: SCP) is listed on Warsaw Stock Exchange, where its shares trade in PLN. It belongs to the Diagnostics & Research industry, part of the Healthcare sector, and reports about 175 employees.
The shares were at 135.20 PLN on 19 November 2026, down 13.2% over 52 weeks. Its 52-week range is 109.00 PLN to 182.20 PLN: the price is 25.8% below the high and 24.0% above the low.
Its market capitalisation is 428.35M PLN.
Scope Fluidics reports return on equity of -28.5% and revenue down 95.1% year over year.
It holds more cash than debt, a net cash position of 116.96M PLN. Its Piotroski F-score is 1 out of 9, a weak reading of its financial health. One analyst covers the stock; their mean price target of 223.90 PLN is 65.6% above the current price.